BCYC Q1 2024 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena

BCYCBicycle Therapeutics plc

$374M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$20M+298.9% YoY

Gross Profit

$20M100.0% margin

Operating Income

-$32M-162.4% margin

Net Income

-$27M-136.0% margin

EPS (Diluted)

$-0.62

QoQ Revenue Growth

+266.3%

Cash Flow

Operating Cash Flow

-$71M

Free Cash Flow

-$71M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$547M

Total Liabilities

$191M

Stockholders' Equity

$356M

Cash & Equivalents

$457M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20M	$5M	+298.9%
Gross Profit	$20M	$5M	+298.9%
Operating Income	-$32M	-$42M	+24.1%
Net Income	-$27M	-$39M	+32.0%